Donepezil for dementia with Lewy bodies: meta-analysis of multicentre, randomised, double-blind, placebo-controlled phase II, III, and, IV studies.
Etsuro MoriManabu IkedaMegumi OhdakePublished in: Psychogeriatrics : the official journal of the Japanese Psychogeriatric Society (2024)
Results of our meta-analysis indicated overall efficacy of donepezil on cognitive impairment and global clinical status in patients with DLB.